Lv11
50 积分 2023-10-09 加入
State-dependent inhibition of Nav1.8 channels by VX-150 and VX-548
1天前
待确认
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
4天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
28天前
已完结
State-dependent inhibition of Nav1.8 channels by VX-150 and VX-548
29天前
已完结
Targeting sodium channels — challenges for acute pain and the leap to chronic pain
29天前
已完结
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
1个月前
已完结
On the relationship between hERG inhibition and the magnitude of QTc prolongation: An in vitro to clinical translational analysis
1个月前
已完结
Drug metabolic stability in early drug discovery to develop potential lead compounds
1个月前
已完结
Exposure–Efficacy Analysis of Asciminib in Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase
1个月前
已完结
VX-548 in the treatment of acute pain
2个月前
已完结
皖公网安备34019202002308
